WHAT YOU NEED TO KNOW U.S. tariffs have prompted affected countries to diversify export markets, reduce their own import duties and pursue bilateral negotiations with Washington. Combined with China’s volume-based procurement policies, these shifts are pushing Indo-Pacific medical cost inflation to a record 12.3 percent in 2025. U.S. President Donald Trump issued an executive order directing drugmakers to cut U.S. prices to “most-favored-nation” levels. The order encourages bypassing intermediaries … Continue Reading